1,585
Views
6
CrossRef citations to date
0
Altmetric
Research Paper

A model of influenza infection and vaccination in children aged under 5 years in Beijing, China

, , , , , , , & show all
Pages 1685-1690 | Received 15 Aug 2019, Accepted 12 Dec 2019, Published online: 29 Jan 2020

References

  • Biezen R, Grando D, Mazza D, Brijnath B. Why do we not want to recommend influenza vaccination to young children? A qualitative study of Australian parents and primary care providers. Vaccine. 2018;36(6):859–65. doi:10.1016/j.vaccine.2017.12.066.
  • Jackson ML, Phillips CH, Benoit J, Jackson LA, Gaglani M, Murthy K, McLean HQ, Belongia EA, Malosh R, Zimmerman R, et al. Burden of medically attended influenza infection and cases averted by vaccination - United States, 2013/14 through 2015/16 influenza seasons. Vaccine. 2018;36(4):467–72. doi:10.1016/j.vaccine.2017.12.014.
  • Poehling KA, Edwards KM, Weinberg GA, Szilagyi P, Staat MA, Iwane MK, Bridges CB, Grijalva CG, Zhu Y, Bernstein DI, et al. The underrecognized burden of influenza in young children. N Engl J Med. 2006;355(1):31–40. doi:10.1056/NEJMoa054869.
  • Cromer D, van Hoek AJ, Jit M, Edmunds WJ, Fleming D, Miller E. The burden of influenza in England by age and clinical risk group: a statistical analysis to inform vaccine policy. J Infect. 2014;68(4):363–71. doi:10.1016/j.jinf.2013.11.013.
  • Wu P, Presanis AM, Bond HS, Lau EHY, Fang VJ, Cowling BJ. A joint analysis of influenza-associated hospitalizations and mortality in Hong Kong, 1998–2013. Sci Rep. 2017;7(1):929. doi:10.1038/s41598-017-01021-x.
  • Yu H, Huang J, Huai Y, Guan X, Klena J, Liu S, Peng Y, Yang H, Luo J, Zheng J, et al. The substantial hospitalization burden of influenza in central China: surveillance for severe, acute respiratory infection, and influenza viruses, 2010–2012. Influenza Other Respir Viruses. 2014;8(1):53–65. doi:10.1111/irv.2013.8.issue-1.
  • Feng L, Yang P, Zhang T, Yang J, Fu C, Qin Y, Zhang Y, Ma C, Liu Z, Wang Q, et al. Technical guidelines for the application of seasonal influenza vaccine in China (2014–2015). Hum Vaccin Immunother. 2015;11(8):2077–101. doi:10.1080/21645515.2015.1027470.
  • World Health Organization. Influenza (Seasonal). [accessed 2019 Oct 10] http://www.who.int/mediacentre/factsheets/fs211/en/.
  • Yang P, Thompson MG, Ma C, Shi W, Wu S, Zhang D, Wang Q. Influenza vaccine effectiveness against medically-attended influenza illness during the 2012–2013 season in Beijing, China. Vaccine. 2014;32(41):5285–89.
  • Beijing Municipal Bureau of Statistics & Survey Office of the National Bureau of Statistics in Beijing. Beijing statistical yearbook. [accessed 2019 Oct 10] http://www.bjstats.gov.cn/nj/main/2016-tjnj/zk/indexch.htm.
  • Qin Y, Zhang Y, Wu P, Feng S, Zheng J, Yang P, Pan Y, Wang Q, Feng L, Pang X, et al. Influenza vaccine effectiveness in preventing hospitalization among Beijing residents in China, 2013–15. Vaccine. 2016;34(20):2329–33. doi:10.1016/j.vaccine.2016.03.068.
  • Zhang Y, Wu P, Feng L, Yang P, Pan Y, Feng S, Qin Y, Zheng J, Puig-Barberà J, Muscatello D, et al. Influenza vaccine effectiveness against influenza-associated hospitalization in 2015/16 season, Beijing, China. Vaccine. 2017;35(23):3129–34. doi:10.1016/j.vaccine.2017.03.084.
  • Castilla J, Martinez-Baz I, Navascues A, Casado I, Aguinaga A, Diaz-Gonzalez J, Delfrade J., Guevara M. Comparison of influenza vaccine effectiveness in preventing outpatient and inpatient influenza cases in older adults, northern Spain, 2010/11 to 2015/16. Euro Surveill. 2018;23(2):pii=16-00780.
  • Zhang Y, Cao Z, Costantino V, Muscatello DJ, Chughtai AA, Yang P, Wang Q. Influenza illness averted by influenza vaccination among school year children in Beijing, 2013–2016. Influenza Other Respir Viruses. 2018;12(6):687–94.
  • Wu S, VAN Asten L, Wang L, McDonald SA, Pan Y, Duan W, Zhang L, Sun Y, Zhang Y, Zhang X, et al. Estimated incidence and number of outpatient visits for seasonal influenza in 2015–2016 in Beijing, China. Epidemiol Infect. 2017;145(16):3334–44. doi:10.1017/S0950268817002369.
  • Wang X, Wu S, Yang P, Li H, Chu Y, Tang Y, Hua W, Zhang H, Li C, Wang Q, et al. Using a community based survey of healthcare seeking behavior to estimate the actual magnitude of influenza among adults in Beijing during 2013–2014 season. BMC Infect Dis. 2017;17(1):120. doi:10.1186/s12879-017-2217-z.
  • Lee S, Golinski M, Chowell G. Modeling optimal age-specific vaccination strategies against pandemic influenza. Bull Math Biol. 2012;74(4):958–80. doi:10.1007/s11538-011-9704-y.
  • Puig-Barbera J, Mira-Iglesias A, Tortajada-Girbes M, Lopez-Labrador FX, Librero-Lopez J, Diez-Domingo J, Carballido-Fernández M, Carratalá-Munuera C, Correcher-Medina P, Gil-Guillén V, et al. Waning protection of influenza vaccination during four influenza seasons, 2011/2012 to 2014/2015. Vaccine. 2017;35(43):5799–807. doi:10.1016/j.vaccine.2017.09.035.
  • Rose MA, Damm O, Greiner W, Knuf M, Wutzler P, Liese JG, Krüger H, Wahn U, Schaberg T, Schwehm M, et al. The epidemiological impact of childhood influenza vaccination using live-attenuated influenza vaccine (LAIV) in Germany: predictions of a simulation study. BMC Infect Dis. 2014;14:40. doi:10.1186/1471-2334-14-40.
  • Weidemann F, Remschmidt C, Buda S, Buchholz U, Ultsch B, Wichmann O. Is the impact of childhood influenza vaccination less than expected: a transmission modelling study. BMC Infect Dis. 2017;17(1):258. doi:10.1186/s12879-017-2344-6.
  • Pitman RJ, Nagy LD, Sculpher MJ. Cost-effectiveness of childhood influenza vaccination in England and Wales: results from a dynamic transmission model. Vaccine. 2013;31(6):927–42. doi:10.1016/j.vaccine.2012.12.010.
  • Ferdinands JM, Fry AM, Reynolds S, Petrie J, Flannery B, Jackson ML, Belongia EA. Intraseason waning of influenza vaccine protection: evidence from the US influenza vaccine effectiveness network, 2011-12 through 2014–15. Clin Infect Dis. 2017;64(5):544–50.
  • Young B, Sadarangani S, Jiang L, Wilder-Smith A, Chen MI. Duration of influenza vaccine effectiveness: a systematic review, meta-analysis, and meta-regression of test-negative design case-control studies. J Infect Dis. 2018;217(5):731–41. doi:10.1093/infdis/jix632.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.